These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8110496)

  • 41. Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model.
    Langdon SP; Crew AJ; Ritchie AA; Muir M; Wakeling A; Smyth JF; Miller WR
    Eur J Cancer; 1994; 30A(5):682-6. PubMed ID: 8080688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen.
    Howe SR; Pass HI; Ethier SP; Matthews WJ; Walker C
    Cancer Res; 1996 Sep; 56(17):4049-55. PubMed ID: 8752178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.
    Hu XF; Veroni M; De Luise M; Wakeling A; Sutherland R; Watts CK; Zalcberg JR
    Int J Cancer; 1993 Nov; 55(5):873-6. PubMed ID: 8244585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells.
    Wosikowski K; Küng W; Hasmann M; Löser R; Eppenberger U
    Int J Cancer; 1993 Jan; 53(2):290-7. PubMed ID: 8425767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
    Kawamura I; Lacey E; Mizota T; Tsujimoto S; Nishigaki F; Manda T; Shimomura K
    Anticancer Res; 1994; 14(2A):427-31. PubMed ID: 8017842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestins.
    Manning DL; Nicholson RI
    Eur J Cancer; 1993; 29A(5):759-62. PubMed ID: 8471335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.
    Huynh HT; Pollak M
    Cancer Res; 1993 Dec; 53(23):5585-8. PubMed ID: 8242606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
    Lee AV; Weng CN; Jackson JG; Yee D
    J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA; Sager R; Webster L
    Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
    Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
    Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines.
    May FE; Johnson MD; Wiseman LR; Wakeling AE; Kastner P; Westley BR
    J Steroid Biochem; 1989 Dec; 33(6):1035-41. PubMed ID: 2615350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells.
    Coradini D; Biffi A; Cappelletti V; Di Fronzo G
    Anticancer Res; 1994; 14(3A):1059-64. PubMed ID: 8074450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media.
    Pratt SE; Pollak MN
    Cancer Res; 1993 Nov; 53(21):5193-8. PubMed ID: 7693333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females.
    Damien E; Price JS; Lanyon LE
    J Bone Miner Res; 2000 Nov; 15(11):2169-77. PubMed ID: 11092397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
    Gottardis MM; Jiang SY; Jeng MH; Jordan VC
    Cancer Res; 1989 Aug; 49(15):4090-3. PubMed ID: 2743303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
    Planas-Silva MD; Waltz PK; Kilker RL
    J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):193-8. PubMed ID: 16464573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.